Literature DB >> 9118283

Periodontal diseases: microbial factors.

J J Zambon1.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 9118283     DOI: 10.1902/annals.1996.1.1.879

Source DB:  PubMed          Journal:  Ann Periodontol        ISSN: 1553-0841


× No keyword cloud information.
  57 in total

1.  Intracellular Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in buccal epithelial cells collected from human subjects.

Authors:  J D Rudney; R Chen; G J Sedgewick
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 2.  Paradigm shift in the pharmacological management of periodontal diseases.

Authors:  Hatice Hasturk; Alpdogan Kantarci; Thomas E Van Dyke
Journal:  Front Oral Biol       Date:  2011-11-11

3.  Porphyromonas gingivalis fimbriae inhibit caspase-3-mediated apoptosis of monocytic THP-1 cells under growth factor deprivation via extracellular signal-regulated kinase-dependent expression of p21 Cip/WAF1.

Authors:  K Ozaki; S Hanazawa
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.

Authors:  Juan A Crosby; Scott C Kachlany
Journal:  Gene       Date:  2006-10-17       Impact factor: 3.688

5.  Alveolar bone levels in adults as assessed on panoramic radiographs. (I) Prevalence, extent, and severity of even and angular bone loss.

Authors:  Hans-Peter Müller; Martin Ulbrich
Journal:  Clin Oral Investig       Date:  2005-04-16       Impact factor: 3.573

Review 6.  Diagnostic biomarkers for oral and periodontal diseases.

Authors:  Mario Taba; Janet Kinney; Amy S Kim; William V Giannobile
Journal:  Dent Clin North Am       Date:  2005-07

7.  Abundant secretion of bioactive interleukin-1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin.

Authors:  P Kelk; R Claesson; L Hänström; U H Lerner; S Kalfas; A Johansson
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

8.  Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans.

Authors:  Nataliya V Balashova; Juan A Crosby; Lourdes Al Ghofaily; Scott C Kachlany
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

9.  Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection.

Authors:  Y T Teng; H Nguyen; X Gao; Y Y Kong; R M Gorczynski; B Singh; R P Ellen; J M Penninger
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

10.  Evaluation of two commercial kits and arbitrarily primed PCR for identification and differentiation of Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, and Haemophilus paraphrophilus.

Authors:  B Doğan; S Asikainen; H Jousimies-Somer
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.